Viking Therapeutics Inc.
VKTX | NASDAQ
$30.11
+$1.12 (+3.86%)
At close: Sep 21, 2026, 4:00 PM ET
$31.67
+$1.56 (+5.18%)
Pre-market:
Sep 22, 2026, 4:59 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -11.03 | -39.84 | -20.45 | -10.68 | -6.57 | -11.26 |
PEG Ratio | -0.05 | -3.63 | -6 | -0.42 | -0.16 | -0.29 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 6.20 | 4.98 | 5.04 | 4.97 | 1.76 | 1.67 |
P/FCF Ratio | -14.22 | -49.98 | -23.93 | -14.92 | -7.46 | -18.77 |
P/OCF Ratio | -14.22 | -49.98 | -23.93 | -14.92 | -7.46 | -18.77 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0.01 | 0 | 0 |
Quick Ratio | 9.33 | 33.09 | 19.19 | 7.61 | 23.98 | 21.11 |
Current Ratio | 9.33 | 33.09 | 19.19 | 7.61 | 23.98 | 21.11 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -7.02K | -1.61K | -1.15K | -1.19K | -3.09K | -402.47 |
Return on Equity | -56.28% | -12.49% | -24.65% | -47.39% | -27.24% | -16.16% |
Return on Assets | -50.25% | -12.11% | -23.31% | -40.86% | -26.10% | -15.40% |
Return on Invested Capital | -61.54% | -17.12% | -28.83% | -47.90% | -27.58% | -17.43% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove VKTX